A Trial Evaluating the Efficacy and Safety of Prophylactic Administration of Concizumab in Haemophilia A and B Patients With Inhibitors
Completed · Phase 2
Conditions studied: Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors
In brief
This trial is conducted in Africa, Asia, Europe and North America. The aim of the trial is to assess the efficacy of concizumab administered s.c. (subcutaneously, under the skin) once daily in preventing bleeding episodes in haemophilia A and B patients with inhibitors.
Key facts
- Study ID
- NCT03196284
- Run by
- Novo Nordisk A/S
- People needed
- 26
- Starts
- 2017-08-10
- Expected to finish
- 2020-01-31
- Last updated by the study team
- 2021-10-22
Who can join
Age: 18 and older. Sex: male. Healthy volunteers: not accepted.
Where it is running
- Novo Nordisk Investigational Site — Los Angeles, California, United States
- Novo Nordisk Investigational Site — Indianapolis, Indiana, United States
- Novo Nordisk Investigational Site — Iowa City, Iowa, United States
- Novo Nordisk Investigational Site — Vienna, Austria
- Novo Nordisk Investigational Site — Toronto, Ontario, Canada
- Novo Nordisk Investigational Site — Zagreb, Croatia
- Novo Nordisk Investigational Site — Århus N, Denmark
- Novo Nordisk Investigational Site — Athens, Greece
- Novo Nordisk Investigational Site — Tel Litwinsky, Israel
- Novo Nordisk Investigational Site — Florence, Italy
- Novo Nordisk Investigational Site — Milan, Italy
- Novo Nordisk Investigational Site — Aichi, Japan
- Novo Nordisk Investigational Site — Nara, Japan
- Novo Nordisk Investigational Site — Tokyo, Japan
- Novo Nordisk Investigational Site — Georgetown, Penang, Malaysia
- Novo Nordisk Investigational Site — Kota Kinabalu, Malaysia
- Novo Nordisk Investigational Site — Madrid, Spain
- Novo Nordisk Investigational Site — Seville, Spain
- Novo Nordisk Investigational Site — Solna, Sweden
- Novo Nordisk Investigational Site — Lviv, Ukraine
- Novo Nordisk Investigational Site — London, United Kingdom
- Novo Nordisk Investigational Site — Sheffield, United Kingdom
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.